Federated Hermes, Inc. Pfizer Inc Transaction History

Federated Hermes, Inc.

$42.5 Billion
Q1 2024

A detailed history of Federated Hermes, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 14,453,542 shares of PFE stock, worth $404 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

14,453,542

Previous 13,347,938 8.28%

Holding current value

$404 Million

Previous $384 Million 4.37%

% of portfolio

0.94%

Previous 0.97%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $28.6 Million - $32.9 Million	1,105,604 Added 8.28%	14,453,542 $401 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $20.4 Million - $26.5 Million	-781,269 Reduced 5.53%	13,347,938 $384 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $47.9 Million - $56 Million	-1,494,153 Reduced 9.56%	14,129,207 $469 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $86.7 Million - $100 Million	2,399,603 Added 18.15%	15,623,360 $573 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $167 Million - $218 Million	4,249,987 Added 47.36%	13,223,757 $540 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $66.9 Million - $87.3 Million	1,602,318 Added 21.74%	8,973,770 $460 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.08 Million - $1.32 Million	24,752 Added 0.34%	7,371,452 $323 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $32.7 Million - $38.8 Million	703,529 Added 10.59%	7,346,700 $385 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $95.7 Million - $119 Million	2,091,343 Added 45.95%	6,643,171 $344 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $80.3 Million - $119 Million	-1,942,179 Reduced 29.91%	4,551,828 $269 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $244 Million - $314 Million	-6,226,238 Reduced 48.95%	6,494,007 $279 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $29.3 Million - $33.2 Million	815,508 Added 6.85%	12,720,245 $498 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $12.4 Million - $13.9 Million	-369,328 Reduced 3.01%	11,904,737 $431 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $33.6 Million - $42.7 Million	-1,002,629 Reduced 7.55%	12,274,065 $452 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $5.81 Million - $6.82 Million	-183,114 Reduced 1.36%	13,276,694 $487 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $101 Million - $123 Million	-3,364,907 Reduced 20.0%	13,459,808 $440 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $23 Million - $32.9 Million	-852,674 Reduced 4.82%	16,824,715 $549 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $202 Million - $229 Million	6,142,206 Added 53.25%	17,677,389 $693 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $207 Million - $268 Million	6,358,483 Added 122.83%	11,535,183 $414 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $151 Million - $170 Million	4,088,974 Added 375.92%	5,176,700 $224 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $4.21 Million - $4.63 Million	112,288 Added 11.51%	1,087,726 $46.2 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $182 Million - $207 Million	-4,719,286 Reduced 82.87%	975,438 $40.4 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $19.6 Million - $23.8 Million	-568,863 Reduced 9.08%	5,694,724 $251 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $108 Million - $116 Million	3,287,377 Added 110.46%	6,263,587 $227 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $16 Million - $18.6 Million	-501,229 Reduced 14.41%	2,976,210 $106 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $19.9 Million - $21.1 Million	598,977 Added 20.81%	3,477,439 $0
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $89.2 Million - $98.3 Million	2,878,462	2,878,462 $103 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Pfizer Inc Transaction History